Last updated: August 10, 2022
Sponsor: Leiden University Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cerebral Ischemia
Stroke
Treatment
N/AClinical Study ID
NCT05388578
P21.113
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The patient is admitted with a clinical diagnosis of a TIA, ischemic or haemorrhagicstroke in the LUMC
- The patient is able to communicate in Dutch (patients with severe aphasia - defined asnot being able to respond to the questionnaires or perform the self-measurements - areexcluded)
- The patient is at least 18 years of age
- The patient will be discharged from the hospital directly to home
- The patient has hypertension during hospital admission as defined by systolic bloodpressure >140mmHg during two separate blood pressure measurements
- The patient has a suitable smartphone and is able to use it in a reasonable sense
Exclusion
Exclusion Criteria:
- The patient does not have internet access at home
- Patient is unwilling to sign the informed consent form
- Patient is considered an incapacitated adult
Study Design
Total Participants: 55
Study Start date:
July 07, 2022
Estimated Completion Date:
July 01, 2023
Study Description
Connect with a study center
Leiden University Medical Center
Leiden, Zuid-Holland 2300RC
NetherlandsActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.